Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Wednesday, October 17, 2007

Jim Cramer's Mad Money Stock Recap Oct. 16th

Align Technology (ALGN): Cramer began his show with a review of a stock that fits into his opinion that vanity plays are good investments. Align makes Invisalign invisible braces. Cramer thinks that the stock will continue to grow, and that it could go up to $38 if his analysis is correct.
Jim then went to the phonelines. The first caller asked about Intuitive Surgical (ISRG), and Cramer said that he would "buy it with abandon" if the stock pulls back. The second caller asked about the laser group LCA Vision (LCAV), and Cramer said that he thinks they are too risky, and that he doesn't trust LCAV at all. Third caller asked about NutriSystem (NTRI), and Cramer said that Herbalife (HLF) is the best stock in that sector.
LKQ (LKQX). Cramer thinks that the stock is a buy because it is the number one supplier in the auto parts market, and he likes that it has a secondary offering, but the stock continued to go up over the offering price. Cramer said this is one of the best tells that he looks for when investing.
After the lightning round Cramer talked about the fact that there is a large market for people with hearing loss, and he thinks that Sonic Innovations (SNCI) is in a position to profit. Cramer thinks that there is some risk when investing in this small company, but he thinks that the stock could go up to $13.
Masimo (MASI) CEO Joe Kiani was on the show. Cramer likes the stock because he thinks it can't be hurt by a lagging economy. Cramer said that this is the type of stock that is not affected by a slowing economy.
Sudden Death: The first caller asked about Home Depot (HD), and Cramer said that he likes Lowe's (LOW) better. The next caller asked about Companhia Vale do Rio Doce (RIO), and Cramer said he likes the stock. The next caller asked about Steve Madden (SHOO), and Cramer said that Phillips-Van Heusen (PVH) is a better stock to own. The last caller asked about Nuance Communications (NUAN), and Cramer said no to the stock.

Labels: , , , , , , ,

Wednesday, August 22, 2007

Jim Cramer's Mad Money Lightning Round Aug. 21st

Bullish Calls:
Aecom Technology (NYSE: ACM - News): 'This may be the cheapest of the infrastructure plays.'Jacobs Engineering Group (NYSE: JEC - News): ' ... at $61, should have been bought today... buy, buy, buy! Infrastructure rocks, as does agriculture!'Wachovia (NYSE: WB - News): 'They just raised the dividend, and they said that the bad loans are under control.'Schlumberger (NYSE: SLB - News): 'SLB, to me, is the cheapest. It went down today, along with the whole group. I feel like you can trade up to quality... you can trade up to SLB.'Transocean (NYSE: RIG - News)Tata Motors (NYSE: TTM - News): 'I think, at $15, TTM makes a huge amount of sense.'E*Trade Financial (NasdaqGS: ETFC - News): 'I would buy some here, and let it come down a bit ... There are many companies that have really bad exposure to this mortgage stuff. ETFC is not one of them.'American Capital Strategies (NasdaqGS: ACAS - News): 'I think that this company is a survivor... a lot of people have tried to call it out a lot of times. They're not going to be successful.'Hudson City Bancorp (NasdaqGS: HCBK - News): 'I think we're in dangerous territory with FSLR. Don't buy, don't buy.'Level 3 Communications (NasdaqGS: LVLT - News): 'I like LVLT for one reason... because I believe there's going to be a bandwidth shortage ... I am picking this as a long-term speculation and, when we run out of bandwidth, I'm not backing away.'Tessera Technologies (NasdaqGS: TSRA - News): 'I thought the quarter was going to be good. I got the quarter wrong. I like the story longer term. now, in the low $30s, I would definitely buy it.'Principal Financial Group (NYSE: PFG - News): 'A very cheap stock ... I really like this stock. I was going to buy it for my charitable trust... I didn't get a chance.'LCA-Vision (NasdaqGS: LCAV - News): 'Upgraded today by Raymond James... a big buyback coming... just finished a buyback. I like it.'IBM (NYSE: IBM - News)
Neutral calls:
Dean Foods (NYSE: DF - News): 'This has become a very problematic story and I've got to tell you something... don't buy, don't buy... I don't think it's over, and the company doesn't think the pain's over too.'Banco Popular (NasdaqGS: BPOP - News)Parker Drilling (NYSE: PKD - News)Foster Wheeler (NasdaqGS: FWLT - News): 'On a day like today, up $7, sell, sell, sell... on the conference call, they made it very clear that contracts were lumpy...every time the stock runs a little, I think it's going to run into selling pressure.'First Solar (FSLS)
Published By SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , , ,

Wednesday, February 14, 2007

Hot Stock Options to Watch Today

AA, BTU, CEPH, GRMN, LCAV, RTP, WM, stock options Most Under Priced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
LCAVision Mar 50 Calls (NasdaqGS:LCAV - News). LCAV's PowerRating is 3.
Most Under Priced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
Cephalon Mar 75 Puts (NasdaqGS:CEPH - News). CEPH's PowerRating is 5.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
Rio Tinto Mar 210 Calls (NYSE:RTP - News). RTP's PowerRating is 5.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Garmin Mar 50 Puts (NasdaqGS:GRMN - News). GRMN's PowerRating is 5.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
Alcoa (NYSE:AA - News). AA's PowerRating is 5.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock. Washington Mutual (NYSE:WM - News). WM's PowerRating is 5.
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
Peabody Energy (NYSE:BTU - News). BTU's PowerRating is 4.
PowerRatings are courtesy of TradingMarkets.com

Labels: , , , , , , ,

Monday, February 12, 2007

Monday's Biggest Gainers

LCA-Vision Inc. (NasdaqGS:LCAV - News) reported fourth-quarter earnings of $7.1 million, or 34 cents a share, up from a year-ago profit of $6.6 million, or 30 cents a share. Revenue jumped 26% in the latest three months to $58.8 million from $46.8 million a year ago. The Cincinnati-based provider of laser vision correction services also said it's increased its quarterly dividend by 50% to 18 cents a share from 12 cents. Looking ahead, LCA-Vision forecast earnings of $2.05 to $2.15 a share for 2007 on revenue growth of 20% to 25%.
Lions Gate (NYSE:LGF - News) reported third-quarter net earnings of $20.5 million, or 17 cents a share, compared with $3.14 million, or 3 cents a share, in the same period last year, driven by revenue from the company's "Saw III" and "Employee of the Month" films.
Loews Corp. (NYSE:LTR - News) reported consolidated net income of $746.5 million, or $1.11 a share, for the fourth quarter, up from a year-ago equivalent profit of $127.6 million, or 8 cents a share. This performance includes contributions from both Loews Group and Carolina Group, whose net income rose to $137.1 million, or $1.26 per Carolina Group share, in the quarter, from $81.6 million, or $1.11 a share, a year earlier. On a continuing operations basis, Loews earned $633.4 million, or $1.15 per share, in the latest quarter. Loews attributed its higher earnings to improved results at CNA Financial , its 89%-owned subsidiary, and Diamond Offshore Drilling , its 54%-owned subsidiary.
Municipal Mortgage & Equity LLC (NYSE:MMA - News) said it knows of no reason why recent trading in the stock has resulted in a decrease in price. Since Monday, shares of the real estate debt and equity financing concern have dropped almost 15%. MuniMae management noted that it is not engaged in sub-prime or any other single family mortgage lending activities, and that its outlook for the multifamily rental sector is positive.
Novelis was in focus after the company agreed to be acquired by Hindalco Industries Ltd. in a deal worth $6 billion, including debt assumption. The consideration values Novelis at $44.93 a share.
OmniVision (NasdaqGS:OVTI - News) unveiled a 5.17 megapixel auto-focus camera module for mobile handsets based on its OV5623 CameraChip sensor. The company also unveiled its TrueFocus camera with Wavefront Coding technology for the mobile handset market.
Onyx Pharmaceuticals (NasdaqGM:ONXX - News) soared after the company and Bayer (NYSE:BAY - News) said a Phase 3 trial of Nexavar to treat advanced liver cancer was closed early due to a positive outcome. Bayer and Onyx will stop the trial and allow all patients enrolled in this trial access to Nexavar. Given that there are limited approved systemic therapies for this disease, the companies will continue discussions with health authorities worldwide, including the U.S. Food and Drug Administration and European health authorities regarding the next steps in filing for approval for the treatment in advanced liver cancer. Nexavar is currently approved in nearly 50 countries, including the United States and in the European Union, for the treatment of patients with advanced kidney cancer.
Shares of Panera Bread Co. (NasdaqGS:PNRA - News) edged higher after Raymond James upgraded the bakery-café chain to strong buy from outperform, citing valuation. The company reported Friday fourth-quarter earnings that rose over year-earlier levels but fell shy of expectations, according to Thomson Financial, and provided an outlook that was slightly below forecasts. Analyst Bryan Elliott noted that the stock traded up most of the day before turning lower at the close. "We believe that that this reflects intermediate and longer-term capital that has been on the sideline waiting for 2007 guidance to be released," Elliott said in a research note. "We believe there is sufficient interest from this class of investor to keep Panera Bread under accumulation for at least the next several months."
R.H. Donnelly (NYSE:RHD - News) was upgraded to overweight from neutral at J.P. Morgan.
Smithfield Foods (NYSE:SFD - News) was upgraded to outperform from market perform at Wachovia Securities. The firm cited expectations about the benefits of recent acquisitions.
Southwest Airlines (NYSE:LUV - News) was upgraded to outperform at Bear Stearns.
Triple Crown Media Inc. (NasdaqGM:TCMI - News) said it swung to a fiscal second-quarter net profit of $418,000, or 8 cents a share. The company, which owns and operates local newspapers and runs a collegiate marketing business offering sports marketing services, reported a loss of $802,000 or 16 cents a share in the year-earlier quarter. Revenue for the quarter jumped to $48.1 million from $12.3 million, driven by the acquisition of the marketing business from Bull Run Corp.
Vodafone Group (NYSE:VOD - News) agreed to acquire Hutchison Telecom's (NYSE:HTX - News) 67% stake in Indian mobile operator Hutchison Essar for $11.1 billion and the assumption of $2 billion in debt.
WCI Communities (NYSE:WCI - News) said it's retained Goldman Sachs to assist it in identifying ways to increase shareholder value. The Bonita Springs, Fla. homebuilder said that it expects to generate $1 billion in free cash flow in 2007, and will look at asset sales to help reduce debt. Once the balance sheet is improved, the company will review strategic alternatives, including possible share repurchases are a sale of the company.
Witness Systems' (NasdaqGS:WITS - News) shares rallied after the company agreed to be acquired by Verint Systems (Other OTC:VRNT.PK - News), a unit of Comverse Technology (Other OTC:CMVT.PK - News), for $27.50 a share, or roughly $950 million.
Zoltek Cos. (NasdaqGM:ZOLT - News) shares rose after the St. Louis-based materials reported a fiscal first-quarter net loss of $5.66 million, or 23 cents a share. The quarter included a charge of $8.4 million related to convertible debt and warrant issuances. In the same quarter last year, the company posted net earnings of $6.29 million, or 3 cents a share. Revenue rose to $30.3 million from $15.6 million.
Published By Michael Baron of MarketWatch

Labels: , , , , , , , , , , , , , , , , , ,

Biggest Gainers Monday

Adeza Biomedical Corp. (NasdaqGS:ADZA - News) agreed to be bought by Cytyc Corp. (NasdaqGS:CYTC - News) for $24 a share, or approximately $450 million, Cytyc will fund the purchase through existing cash, the cash on Adeza's balance sheet, and existing credit facilities. The deal, which is subject to customary closing conditions and regulatory approvals, is expected to be completed before the end of March. Cytyc said that, excluding one-time costs related to the acquisition, it expects the acquisition to be break-even to earnings in 2007 and at least accretive by 5 cents to 2008 earnings per share.
Adobe Systems (NasdaqGS:ADBE - News) was upgraded to buy from Oppenheimer & Co., which cited valuation.
Align Technology (NasdaqGM:ALGN - News) shares rose after Piper Jaffray upgraded the teeth misalignment treatment company to outperform from market perform, citing evidence of growing demand for its Invisalign product. Analyst Raj Denhoy also raised his stock price target to $21 from $15, his forecast for 2007 revenue from orthodontists to $85 million from $79 million. "Overall, orthodontists expect their use of Invisalign to increase by approximately 13.4% over the next 12 months; we had previously modeled just 10.6%," Denhoy said in a research note.
Apogee Enterprises (NasdaqGS:APOG - News) lifted its outlook for fiscal 2007, saying it now sees earnings of $1.04 to $1.10 a share. Its previous projection was for a profit of 98 cents to $1.04 a share for the year. The average estimate of analysts polled by Thomson Financial is for a profit of $1.01 a share in 2007. The Minneapolis-based glass products maker anticipates it will post revenue growth near the top of its prior range of 12% to 15%. For fiscal 2008, Apogee forecast earnings of $1.20 to $1.30 a share on revenue growth of 8% to 11%. Wall Street's current consensus estimate is for a profit of $1.19 a share in fiscal 2008.
Apple Inc. (NasdaqGS:AAPL - News) was upgraded to buy from hold at Citigroup, which cited several meaningful product catalysts and expectations of significant gross market upside due to declines in flash memory and DRAM (dynamic random access memory) pricing. Analyst Richard Gardner kept his 12-month price target at $105.
Asta Funding (NasdaqGS:ASFI - News) agreed to acquire a portfolio with a face value of $6.9 billion for a purchase price of $300 million. Asta said the portfolio is made up of primarily credit card accounts.
Brush Wellman (NYSE:BW - News) said its fourth-quarter earnings jumped to $30.3 million, or $1.48 a share, from $4.1 million, or 93 cents a share, a year earlier, boosted by a $21.3 million benefit related to the reversal of the company's deferred tax valuation allowance. The Cleveland supplier of metal products and engineered material systems said excluding the allowance, the company earned 44 cents a share. Revenue rose 48% to $207.8 million from $140.6 million a year ago. Analysts surveyed by Thomson Financial expected, on average, earnings of 41 cents a share on revenue of $189 million. Analyst earnings forecasts typically exclude unusual items. In addition, Brush Engineered said it expects 2007 sales to rise 25% to 30%to $950 million to $1 billion, with earnings of $3 to $3.75 a share, including a $1-per-share benefit from the sale of inventory.
Cell Therapeutics (NasdaqGM:CTIC - News) said it plans to form a new company, Aequus BioPharma, Inc., and spin it off. The company didn't provide details of whether the spin-off will be in the form of an initial public offering or a dividend to its shareholders.
Ciena Corp. (NasdaqGS:CIEN - News) was upgraded by Credit Suisse to outperform from neutral, citing the networking company's strong competitive position in the rebounding optical infrastructure market. Analyst Paul Silverstein also lifted his stock price target to $36 from $29.25, his 2007 earnings estimate to 93 cents a share from 91 cents and his 2007 revenue forecast to $715 million from $710 million. The stock was up 2.2% at $28.90 in pre-open trading. "We expect to see further sustained increase in demand due to increasing bandwidth consumption and the concomitant need for network re-architecture driven primarily by increasing amounts of video on service provider and enterprise networks," Silverstein said in a research note.
Digital Music Group (NasdaqGM:DMGI - News) signed a revenue-sharing content agreement with YouTube. The deal calls for certain components of Digital Music's video and music catalog to be made available by YouTube. Financial terms weren't disclosed.
Diversa Corp. (NasdaqGM:DVSA - News) shares gained after the San Diego-based maker of specialty enzymes said it has agreed to merge with privately held Celunol Corp, a developer of technology for producing ethanol from cellulosic biomass feedstocks. Under the terms of the deal, Diversa will issue 15 million shares to acquire the outstanding equity of Celunol. Diversa will also provide Celunol with up to $20 million in debt financing to fund its operations prior to the closing of the transaction. Diversa stockholders will own roughly 76% of the combined company, and Celunol stockholders and option holders will own 24%. The deal is expected to close by the end of the second quarter.
Express Scripts (NasdaqGS:ESRX - News) was upgraded to buy from hold at Jefferies & Co. The firm boosted its price target on the stock to $90 from $77.
Grubb & Ellis Co. (NYSE:GBE - News) said its second-quarter net income rose to $6.1 million, or 23 cents a share, from $4.9 million, or 36 cents, a year earlier. The average earnings estimate of four analysts surveyed by Thomson Financial was 9 cents a share. The Chicago real-estate services company said revenue for the three months ended Dec. 31 rose to $145.8 million from $140.6 million.
Home Depot Inc. (NYSE:HD - News) said its board has decided to evaluate strategic alternatives for its HD Supply business, including a possible sale, spin-off or initial public offering. The Atlanta-based retailer said there can be no assurance that any deal will occur or its timing. Home Depot said it hired Lehman Brothers as its financial advisor and it does not expect to update its progress or disclose developments with respect to the exploration of HD Supply strategic alternatives unless the board of directors has approved a definitive transaction.
Hydril (NasdaqGS:HYDL - News) shares leapt after the manufacturer of pressure control products for oil and gas production agreed to be acquire by Tenaris S.A. for $97 a share in cash. The offer represents a premium of roughly 17% to Hydril's closing share price last Friday. The deal is expected to close in the second quarter. Certain members of the Seaver family have agreed to vote Hydril shares, representing roughly 22% of the combined votes rights, in favor of the merger, Luxembourg-based Tenaris said.
Infineon AG (NYSE:IFX - News) was approached by at least three private equity groups in the last six months, according to a report in the Financial Times newspaper. The firm's management do not want a deal, but some potential bidders remain hopeful a deal could still be possible this year, the newspaper said, citing a person familiar with the situation. If Infineon, which has a market capitalization of 8 billion euros ($10.4 billion), were bought, it would be the largest private equity deal ever in Germany, the FT added.
Kraft Foods (NYSE:KFT - News) was upgraded to neutral from reduce at UBS.
Kronos Inc. (NasdaqGS:KRON - News) was upgraded to strong buy from buy at Needham & Co. The firm lifted its price target on the stock to $50.
Lamson & Sessions (NYSE:LMS - News) said its board hired Perella Weinberg Partners as financial adviser to explore "a range of strategic and financial alternatives" for the company. The Cleveland thermoplastics company said the potential actions include the sale of certain assets or the entire company, formation of joint ventures, a change to the company's capital structure, or a continuation of the company's business plan.
LCA-Vision Inc. (NasdaqGS:LCAV - News) reported fourth-quarter earnings of $7.1 million, or 34 cents a share, up from a year-ago profit of $6.6 million, or 30 cents a share. Revenue jumped 26% in the latest three months to $58.8 million from $46.8 million a year ago. The Cincinnati-based provider of laser vision correction services also said it's increased its quarterly dividend by 50% to 18 cents a share from 12 cents. Looking ahead, LCA-Vision forecast earnings of $2.05 to $2.15 a share for 2007 on revenue growth of 20% to 25%.
Published By Michael Baron of MarketWatch

Labels: , , , , , , , , , , , , , , , , , , ,

This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed GRB Holding Co., LLC

;